JAMDA
Volume 9, Issue 1 , Pages 18-28 , January 2008

Atypical Antipsychotics for the Treatment of Delirious Elders

  • Lauren B. Ozbolt, MD

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Mental Health Hospital Center, University of Miami Miller School of Medicine, Miami, FL
    • Corresponding Author InformationAddress correspondence to Lauren Ozbolt, MD, University of Miami, Miller School of Medicine, Psychiatric Residency Training, Jackson Memorial Hospital, 1695 NW 9th Ave #2101, Miami, FL 33136.
    • ,
  • Miguel A. Paniagua, MD

      Affiliations

    • Division of Gerontology and Geriatric Medicine, St. Louis University Department of Medicine, St Louis, MO
    • ,
  • Robert M. Kaiser, MD, MHSc

      Affiliations

    • University of Miami Miller School of Medicine, Miami VA Geriatric Research Education and Clinical Center, Miami, FL.

References 

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. In: 4th ed. Washington, DC: American Psychiatric Association; 1994;p. 129–133
  2. Kaplan H, Sadock B. Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry. 1998;MD: Philadelphia, PA Lippincott Williams & Wilkins
  3. Katz PR, Grossberg GT, Potter JF, et al. Delirium. Geriatrics Syllabus for Specialists. 2002;26:2
  4. Nayeem K, O’Keeffe ST. CME elderly medicine. Clin Med. 2003;3(5):412–415
  5. Inouye SK. Delirium in older persons. N Engl J Med. 2006;354(11):1157–1165
  6. Thorp L. The treatment of psychotic disorders in late life. Can J Psychiatry. 1997;42(Suppl 1):19S–27S
  7. Mittal D, Jimerson NA, Neely EP, et al. Risperidone in the treatment of delirium: Results from a prospective open–label trial. J Clin Psychiatry. 2004;65(5):662–667
  8. Han C, Kim Y. A double–blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004;45(4):297–301
  9. Nassisi D, Korc B, Hahn S, et al. The evaluation and management of the acutely agitated elderly patient. Mt Sinai J Med. 2006;73(7):976–984
  10. Targum SD. Treating psychotic symptoms in elderly patients (Primary Care Companion). J Clin Psychiatry. 2001;3(4):156–163
  11. Jackson JC. Delirium and long–term cognitive impairment: An overview. Clinical Window Web Journal: Outcome after Intensive Care Delirium, #21, Vol. 6, January 2006 http://www.clinicalwindow.netAccessed July 27, 2007
  12. Rathier MO, McElhaney J. Delirium in elderly patients: How you can help. Applied Neurology. 2005;August
  13. Schwartz TL, Masand PS. The role of atypical antipsychotics in the treatment of delirium. Psychosomatics. 2002;43(3):171–173
  14. Flaherty JH, Rudolph J, Shay K, et al. Delirium is a serious and under–recognized problem: Why assessment of mental status should be the sixth vital sign. J Am Med Dir Assoc. 2007;273–275
  15. Shingo M, Yamamoto K, Hoshino S, et al. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry Clin Neurosci. 2007;61:275–282
  16. Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital–associated delirium in medically or surgically ill patients. Ann Pharmacother. 2006;40:1966–1973
  17. Sipahimalani A, Masand P. Use of risperidone in delirium: Case reports. Ann Clin Psychiatry. 1997;9(2):105–107
  18. Bourgeois JA, Hilty DM. Prolonged delirium managed with risperidone. Psychosomatics. 2005;46(1):90–91
  19. Ravona–Springer R, Dolberg OT, Hirschmann S, et al. Delirium in elderly patients treated with risperidone: A report of three cases. J Clin Psychopharmacol. 1998;18(2):171–172
  20. Horikawa N, Yamazaki T, Miyamoto K, et al. Treatment of delirium with risperidone: Results of a prospective open trial with 10 patients. Gen Hosp Psychiatry. 2003;25(4):289–292
  21. Zarate CA, Baldessarini RJ, Siegel AJ, et al. Risperidone in the elderly: A pharmacoepidemiologic study. J Clin Psychiatry. 1997;58(7):311–317
  22. Gupta N, Sharma P, Mattoo SK. Effectiveness of risperidone in delirium. Can J Psychiatry. 2005;50:75
  23. Lim CJ, Trevino C, Tampi RR. Can olanzapine cause delirium in the elderly?. Ann Pharmacother. 2006;40:135–138
  24. Skrobik Y, Bergeron N, Dumont M, et al. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intens Care Med. 2004;30:444–449
  25. Breitbart W, Tremblay A, Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics. 2002;43(3):175–182
  26. Kim K, Pae C, Chae J, et al. An open pilot trial of olanzapine for delirium in the Korean population. Psychiatry Clin Neurosci. 2001;55:515–519
  27. Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics. 1998;39:422–430
  28. Kim KY, Bader GM, Kotlyar V, et al. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol. 2003;16(1):29–32
  29. Sasaki Y, Matsuyama T, Inoue S, et al. A prospective, open–label, flexible–dose study of quetiapine in the treatment of delirium. J Clin Psychiatry. 2003;64(11):1316–1321
  30. Neil W, Curran S, Wattis J. Antipsychotic prescribing in older people. Age Ageing. 2003;32(5):475–483
  31. Zayas EM, Grossberg GT. The treatment of psychosis in later life. J Clin Psychiatry. 1998;59(suppl 1):5–10
  32. Mosby’s Drug Consult. Mosby, Inc http://www.mdconsult.com2006;Accessed February 16, 2006
  33. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta–analysis of randomized placebo–controlled trials. JAMA. 2005;294:1934–1943
  34. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353(22):2335–2341
  35. Herrmann N, Mamdani M, Lanctot K. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry. 2004;161(6):1113–1115
  36. Glassman AH, Bigger JT. Antipsychotic drugs: Prolonged QTc interval, Torsade de Pointes, and sudden death. Am J Psychiatry. 2001;158:1774–1782
  37. Gill SS, Rochon PA, Herrmann N, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: Population based retrospective cohort study. BMJ. 2005;330:445–451
  38. Layton D, Harris S, Wilton L, et al. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. J Psychopharmacol. 2005;19(5):473–482
  39. Ryan CJ. Optimising management of delirium. BMJ. 2001;322:1602
  40. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. N Engl J Med. 2006;355(15):1525–1538
  41. Pitkala KH, Laurila JV, Strandberg TE, et al. Multicomponent geriatric intervention for elderly inpatients with delirium: A randomized, controlled trial. J Gerontol. 2006;61(2):176–181
  42. Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340(9):669–676

PII: S1525-8610(07)00358-1

doi: 10.1016/j.jamda.2007.08.007

JAMDA
Volume 9, Issue 1 , Pages 18-28 , January 2008

Article Tools